Blueprint Medicines Corp (BPMC)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch BPMC
See up to 3 months of BPMC. The 7-day demo opens the 1M and 3M ranges and puts BPMC on your watchlist.
Start 7-day demoLatest BPMC insider trades
About Blueprint Medicines Corp (BPMC)
Blueprint Medicines Corp files with the SEC under CIK 0001597264 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
BPMC Form 4 activity by transaction type, last 90 days
No Form 4 activity for BPMC in the last 90 days.
BPMC insider transactions (Form 4)
20328 Form 4 filings on record, the earliest from Oct 4, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Habib J. Dable - Director | Derivative | Common Stock | 3,902 | - | - | |
| Habib J. Dable - Director | Other | Common Stock | 8,742 | - | - | |
| Habib J. Dable - Director | Derivative | Stock Option (Right to Buy) | 7,950 | - | - | |
| Habib J. Dable - Director | Derivative | Stock Option (Right to Buy) | 5,300 | - | - | |
| Habib J. Dable - Director | Derivative | Stock Option (Right to Buy) | 4,570 | - | - | |
| Michael Landsittel - Officer | Grant or award | Common Stock | 21,353 | - | - | |
| Michael Landsittel - Officer | Derivative | Common Stock | 51,102 | - | - | |
| Michael Landsittel - Officer | Other | Common Stock | 43,175 | - | - | |
| Michael Landsittel - Officer | Derivative | Stock Option (Right to Buy) | 10,000 | - | - | |
| Michael Landsittel - Officer | Derivative | Stock Option (Right to Buy) | 26,000 | - | - | |
| Michael Landsittel - Officer | Derivative | Stock Option (Right to Buy) | 19,500 | - | - | |
| Michael Landsittel - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Michael Landsittel - Officer | Derivative | Stock Option (Right to Buy) | 26,125 | - | - | |
| Michael Landsittel - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Michael Landsittel - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Michael Landsittel - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Michael Landsittel - Officer | Derivative | Stock Option (Right to Buy) | 22,000 | - | - | |
| Ariel Hurley - Officer | Grant or award | Common Stock | 2,460 | - | - | |
| Ariel Hurley - Officer | Derivative | Common Stock | 16,146 | - | - | |
| Ariel Hurley - Officer | Other | Common Stock | 3,378 | - | - | |
| Ariel Hurley - Officer | Derivative | Stock Option (Right to Buy) | 2,250 | - | - | |
| Ariel Hurley - Officer | Derivative | Stock Option (Right to Buy) | 12,000 | - | - | |
| Ariel Hurley - Officer | Derivative | Stock Option (Right to Buy) | 11,399 | - | - | |
| Ariel Hurley - Officer | Derivative | Stock Option (Right to Buy) | 2,751 | - | - | |
| Ariel Hurley - Officer | Derivative | Stock Option (Right to Buy) | 6,375 | - | - | |
| Ariel Hurley - Officer | Derivative | Stock Option (Right to Buy) | 5,750 | - | - | |
| Ariel Hurley - Officer | Derivative | Stock Option (Right to Buy) | 9,494 | - | - | |
| Ariel Hurley - Officer | Derivative | Stock Option (Right to Buy) | 10,000 | - | - | |
| Ariel Hurley - Officer | Derivative | Stock Option (Right to Buy) | 7,007 | - | - | |
| John Tsai - Director | Derivative | Common Stock | 3,902 | - | - | |
| John Tsai - Director | Other | Common Stock | 8,742 | - | - | |
| John Tsai - Director | Derivative | Stock Option (Right to Buy) | 7,950 | - | - | |
| John Tsai - Director | Derivative | Stock Option (Right to Buy) | 5,300 | - | - | |
| John Tsai - Director | Derivative | Stock Option (Right to Buy) | 4,570 | - | - | |
| L. Becker Hewes - Officer | Grant or award | Common Stock | 21,353 | - | - | |
| L. Becker Hewes - Officer | Derivative | Common Stock | 50,165 | - | - | |
| L. Becker Hewes - Officer | Other | Common Stock | 1,607 | - | - | |
| L. Becker Hewes - Officer | Derivative | Stock Option (Right to Buy) | 13,490 | - | - | |
| L. Becker Hewes - Officer | Derivative | Stock Option (Right to Buy) | 26,125 | - | - | |
| L. Becker Hewes - Officer | Derivative | Stock Option (Right to Buy) | 9,115 | - | - | |
| L. Becker Hewes - Officer | Derivative | Stock Option (Right to Buy) | 19,271 | - | - | |
| L. Becker Hewes - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| L. Becker Hewes - Officer | Derivative | Stock Option (Right to Buy) | 22,000 | - | - | |
| Lonnel Coats - Director | Derivative | Common Stock | 6,144 | - | - | |
| Lonnel Coats - Director | Derivative | Stock Option (Right to Buy) | 11,818 | - | - | |
| Lonnel Coats - Director | Derivative | Stock Option (Right to Buy) | 10,909 | - | - | |
| Lonnel Coats - Director | Derivative | Stock Option (Right to Buy) | 10,909 | - | - | |
| Lonnel Coats - Director | Derivative | Stock Option (Right to Buy) | 4,875 | - | - | |
| Lonnel Coats - Director | Derivative | Stock Option (Right to Buy) | 3,188 | - | - | |
| Lonnel Coats - Director | Derivative | Stock Option (Right to Buy) | 4,500 | - | - | |
| Lonnel Coats - Director | Derivative | Stock Option (Right to Buy) | 5,300 | - | - | |
| Lonnel Coats - Director | Derivative | Stock Option (Right to Buy) | 5,300 | - | - | |
| Lonnel Coats - Director | Derivative | Stock Option (Right to Buy) | 4,570 | - | - | |
| Kate Haviland - Officer | Grant or award | Common Stock | 129,210 | - | - | |
| Kate Haviland - Officer | Derivative | Common Stock | 224,410 | - | - | |
| Kate Haviland - Officer | Other | Common Stock | 70,729 | - | - | |
| Kate Haviland - Officer | Derivative | Stock Option (Right to Buy) | 2 | - | - | |
| Kate Haviland - Officer | Derivative | Stock Option (Right to Buy) | 591 | - | - | |
| Kate Haviland - Officer | Derivative | Stock Option (Right to Buy) | 39,000 | - | - | |
| Kate Haviland - Officer | Derivative | Stock Option (Right to Buy) | 32,500 | - | - | |
| Kate Haviland - Officer | Derivative | Stock Option (Right to Buy) | 28,500 | - | - | |
| Kate Haviland - Officer | Derivative | Stock Option (Right to Buy) | 26,125 | - | - | |
| Kate Haviland - Officer | Derivative | Stock Option (Right to Buy) | 80,000 | - | - | |
| Kate Haviland - Officer | Derivative | Stock Option (Right to Buy) | 80,000 | - | - | |
| Kate Haviland - Officer | Derivative | Stock Option (Right to Buy) | 80,000 | - | - | |
| Kate Haviland - Officer | Derivative | Stock Option (Right to Buy) | 70,400 | - | - | |
| Percy H. Carter - Officer | Grant or award | Common Stock | 21,353 | - | - | |
| Percy H. Carter - Officer | Derivative | Common Stock | 56,614 | - | - | |
| Percy H. Carter - Officer | Other | Common Stock | 17,894 | - | - | |
| Percy H. Carter - Officer | Derivative | Stock Option (Right to Buy) | 39,200 | - | - | |
| Percy H. Carter - Officer | Derivative | Stock Option (Right to Buy) | 17,500 | - | - | |
| Percy H. Carter - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Percy H. Carter - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Percy H. Carter - Officer | Derivative | Stock Option (Right to Buy) | 22,000 | - | - | |
| Christina Rossi - Officer | Grant or award | Common Stock | 39,456 | - | - | |
| Christina Rossi - Officer | Derivative | Common Stock | 82,374 | - | - | |
| Christina Rossi - Officer | Other | Common Stock | 20,628 | - | - | |
| Christina Rossi - Officer | Derivative | Stock Option (Right to Buy) | 80,000 | - | - | |
| Christina Rossi - Officer | Derivative | Stock Option (Right to Buy) | 6,500 | - | - | |
| Christina Rossi - Officer | Derivative | Stock Option (Right to Buy) | 28,500 | - | - | |
| Christina Rossi - Officer | Derivative | Stock Option (Right to Buy) | 26,125 | - | - | |
| Christina Rossi - Officer | Derivative | Stock Option (Right to Buy) | 30,000 | - | - | |
| Christina Rossi - Officer | Derivative | Stock Option (Right to Buy) | 30,000 | - | - | |
| Christina Rossi - Officer | Derivative | Stock Option (Right to Buy) | 30,000 | - | - | |
| Christina Rossi - Officer | Derivative | Stock Option (Right to Buy) | 26,400 | - | - | |
| Fouad Namouni - Officer | Grant or award | Common Stock | 39,456 | - | - | |
| Fouad Namouni - Officer | Derivative | Common Stock | 83,281 | - | - | |
| Fouad Namouni - Officer | Other | Common Stock | 31,956 | - | - | |
| Fouad Namouni - Officer | Derivative | Stock Option (Right to Buy) | 65,000 | - | - | |
| Fouad Namouni - Officer | Derivative | Stock Option (Right to Buy) | 26,125 | - | - | |
| Fouad Namouni - Officer | Derivative | Stock Option (Right to Buy) | 30,000 | - | - | |
| Fouad Namouni - Officer | Derivative | Stock Option (Right to Buy) | 30,000 | - | - | |
| Fouad Namouni - Officer | Derivative | Stock Option (Right to Buy) | 30,000 | - | - | |
| Fouad Namouni - Officer | Derivative | Stock Option (Right to Buy) | 26,400 | - | - | |
| Tracey L. McCain - Officer | Grant or award | Common Stock | 21,353 | - | - | |
| Tracey L. McCain - Officer | Derivative | Common Stock | 51,103 | - | - | |
| Tracey L. McCain - Officer | Other | Common Stock | 37,092 | - | - | |
| Tracey L. McCain - Officer | Derivative | Stock Option (Right to Buy) | 55,000 | - | - | |
| Tracey L. McCain - Officer | Derivative | Stock Option (Right to Buy) | 5,000 | - | - | |
| Tracey L. McCain - Officer | Derivative | Stock Option (Right to Buy) | 39,000 | - | - | |
| Tracey L. McCain - Officer | Derivative | Stock Option (Right to Buy) | 29,900 | - | - | |
| Tracey L. McCain - Officer | Derivative | Stock Option (Right to Buy) | 28,500 | - | - | |
| Tracey L. McCain - Officer | Derivative | Stock Option (Right to Buy) | 26,125 | - | - | |
| Tracey L. McCain - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Tracey L. McCain - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Tracey L. McCain - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Tracey L. McCain - Officer | Derivative | Stock Option (Right to Buy) | 22,000 | - | - | |
| Debra Durso-Bumpus - Officer | Grant or award | Common Stock | 21,353 | - | - | |
| Debra Durso-Bumpus - Officer | Derivative | Common Stock | 51,103 | - | - | |
| Debra Durso-Bumpus - Officer | Other | Common Stock | 19,856 | - | - | |
| Debra Durso-Bumpus - Officer | Derivative | Stock Option (Right to Buy) | 15,367 | - | - | |
| Debra Durso-Bumpus - Officer | Derivative | Stock Option (Right to Buy) | 30,500 | - | - | |
| Debra Durso-Bumpus - Officer | Derivative | Stock Option (Right to Buy) | 21,125 | - | - | |
| Debra Durso-Bumpus - Officer | Derivative | Stock Option (Right to Buy) | 26,125 | - | - | |
| Debra Durso-Bumpus - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Debra Durso-Bumpus - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Debra Durso-Bumpus - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Debra Durso-Bumpus - Officer | Derivative | Stock Option (Right to Buy) | 22,000 | - | - | |
| Philina Lee - Officer | Grant or award | Common Stock | 21,353 | - | - | |
| Philina Lee - Officer | Derivative | Common Stock | 50,165 | - | - | |
| Philina Lee - Officer | Other | Common Stock | 13,184 | - | - | |
| Philina Lee - Officer | Derivative | Stock Option (Right to Buy) | 8,650 | - | - | |
| Philina Lee - Officer | Derivative | Stock Option (Right to Buy) | 6,928 | - | - | |
| Philina Lee - Officer | Derivative | Stock Option (Right to Buy) | 20,669 | - | - | |
| Philina Lee - Officer | Derivative | Stock Option (Right to Buy) | 25,000 | - | - | |
| Philina Lee - Officer | Derivative | Stock Option (Right to Buy) | 22,000 | - | - | |
 Jeffrey W. Albers - Director | Derivative | Common Stock | 5,777 | - | - | |
| Jeffrey W. Albers - Director | Other | Common Stock | 144,755 | - | - | |
| Jeffrey W. Albers - Director | Derivative | Stock Option (Right to Buy) | 92,500 | - | - | |
| Jeffrey W. Albers - Director | Derivative | Stock Option (Right to Buy) | 170,000 | - | - | |
| Jeffrey W. Albers - Director | Derivative | Stock Option (Right to Buy) | 110,500 | - | - | |
| Jeffrey W. Albers - Director | Derivative | Stock Option (Right to Buy) | 90,000 | - | - | |
| Jeffrey W. Albers - Director | Derivative | Stock Option (Right to Buy) | 80,000 | - | - | |
| Jeffrey W. Albers - Director | Derivative | Stock Option (Right to Buy) | 15,000 | - | - | |
| Jeffrey W. Albers - Director | Derivative | Stock Option (Right to Buy) | 5,300 | - | - | |
| Jeffrey W. Albers - Director | Derivative | Stock Option (Right to Buy) | 4,570 | - | - | |
| Mark Alan Goldberg - Director | Derivative | Common Stock | 3,902 | - | - | |
| Mark Alan Goldberg - Director | Other | Common Stock | 18,254 | - | - | |
| Mark Alan Goldberg - Director | Derivative | Stock Option (Right to Buy) | 10,909 | - | - | |
| Mark Alan Goldberg - Director | Derivative | Stock Option (Right to Buy) | 7,500 | - | - | |
| Mark Alan Goldberg - Director | Derivative | Stock Option (Right to Buy) | 4,875 | - | - | |
| Mark Alan Goldberg - Director | Derivative | Stock Option (Right to Buy) | 4,500 | - | - | |
| Mark Alan Goldberg - Director | Derivative | Stock Option (Right to Buy) | 4,500 | - | - | |
| Mark Alan Goldberg - Director | Derivative | Stock Option (Right to Buy) | 5,300 | - | - | |
| Mark Alan Goldberg - Director | Derivative | Stock Option (Right to Buy) | 5,300 | - | - | |
| Mark Alan Goldberg - Director | Derivative | Stock Option (Right to Buy) | 4,570 | - | - | |
 Daniella Beckman - Director | Derivative | Common Stock | 3,902 | - | - | |
| Daniella Beckman - Director | Other | Common Stock | 10,842 | - | - | |
| Daniella Beckman - Director | Derivative | Stock Option (Right to Buy) | 7,000 | - | - | |
| Daniella Beckman - Director | Derivative | Stock Option (Right to Buy) | 5,300 | - | - | |
| Daniella Beckman - Director | Derivative | Stock Option (Right to Buy) | 5,300 | - | - | |
| Daniella Beckman - Director | Derivative | Stock Option (Right to Buy) | 4,570 | - | - | |
 Lynn Seely - Director | Derivative | Common Stock | 3,902 | - | - | |
| Lynn Seely - Director | Other | Common Stock | 13,254 | - | - | |
| Lynn Seely - Director | Derivative | Stock Option (Right to Buy) | 21,818 | - | - | |
| Lynn Seely - Director | Derivative | Stock Option (Right to Buy) | 10,909 | - | - | |
| Lynn Seely - Director | Derivative | Stock Option (Right to Buy) | 10,909 | - | - | |
| Lynn Seely - Director | Derivative | Stock Option (Right to Buy) | 7,500 | - | - | |
| Lynn Seely - Director | Derivative | Stock Option (Right to Buy) | 4,875 | - | - | |
| Lynn Seely - Director | Derivative | Stock Option (Right to Buy) | 4,500 | - | - | |
| Lynn Seely - Director | Derivative | Stock Option (Right to Buy) | 4,500 | - | - | |
| Lynn Seely - Director | Derivative | Stock Option (Right to Buy) | 5,300 | - | - | |
| Lynn Seely - Director | Derivative | Stock Option (Right to Buy) | 5,300 | - | - | |
| Lynn Seely - Director | Derivative | Stock Option (Right to Buy) | 4,570 | - | - | |
| Alexis Borisy - Director | Derivative | Common Stock | 3,902 | - | - | |
| Alexis Borisy - Director | Other | Common Stock | 74,160 | - | - | |
| Alexis Borisy - Director | Derivative | Stock Option (Right to Buy) | 7,500 | - | - | |
| Alexis Borisy - Director | Derivative | Stock Option (Right to Buy) | 4,875 | - | - | |
| Alexis Borisy - Director | Derivative | Stock Option (Right to Buy) | 4,500 | - | - | |
| Alexis Borisy - Director | Derivative | Stock Option (Right to Buy) | 4,500 | - | - | |
| Alexis Borisy - Director | Derivative | Stock Option (Right to Buy) | 5,300 | - | - | |
| Alexis Borisy - Director | Derivative | Stock Option (Right to Buy) | 5,300 | - | - | |
| Alexis Borisy - Director | Derivative | Stock Option (Right to Buy) | 4,570 | - | - | |
| Christina Rossi - Officer | Open-market sale | Common Stock | 1,172 | $128.25 | $150K | |
| Percy H. Carter - Officer | Open-market sale | Common Stock | 1,051 | $128.25 | $135K | |
| Jeffrey W. Albers | Option exercise | Common Stock | 15,000 | $36.05 | $541K | |
| Jeffrey W. Albers | Open-market sale | Common Stock | 3,920 | $88.28 | $346K | |
| Jeffrey W. Albers | Open-market sale | Common Stock | 5,180 | $89.01 | $461K | |
| Jeffrey W. Albers | Open-market sale | Common Stock | 3,800 | $91.15 | $346K | |
| Jeffrey W. Albers | Open-market sale | Common Stock | 2,100 | $91.96 | $193K | |
| Jeffrey W. Albers | Option exercise | Stock Option (Right to Buy) | 15,000 | $36.05 | $541K | |
| Christina Rossi - Officer | Open-market sale | Common Stock | 2,166 | $95.88 | $208K | |
| Christina Rossi - Officer | Open-market sale | Common Stock | 108 | $96.50 | $10K | |
| Ariel Hurley - Officer | Option exercise | Common Stock | 1,600 | $15.01 | $24K | |
| Ariel Hurley - Officer | Open-market sale | Common Stock | 1,200 | $92.88 | $111K | |
| Ariel Hurley - Officer | Open-market sale | Common Stock | 619 | $93.99 | $58K | |
| Ariel Hurley - Officer | Option exercise | Stock Option (Right to Buy) | 1,600 | $15.01 | $24K | |
| Kate Haviland - Officer | Open-market sale | Common Stock | 400 | $95.40 | $38K | |
| Kate Haviland - Officer | Open-market sale | Common Stock | 1,746 | $96.74 | $169K | |
| Kate Haviland - Officer | Open-market sale | Common Stock | 207 | $97.76 | $20K | |
| Christina Rossi - Officer | Open-market sale | Common Stock | 2,274 | $95.10 | $216K | |
| Lonnel Coats | Option exercise | Common Stock | 7,500 | $69.79 | $523K | |
| Lonnel Coats | Option exercise | Common Stock | 1,312 | $76.24 | $100K | |
| Lonnel Coats | Open-market sale | Common Stock | 4,500 | $93.15 | $419K | |
| Lonnel Coats | Open-market sale | Common Stock | 5,287 | $94.24 | $498K | |
| Lonnel Coats | Open-market sale | Common Stock | 213 | $94.99 | $20K | |
| Lonnel Coats | Open-market sale | Common Stock | 9,824 | $94.87 | $932K | |
| Lonnel Coats | Option exercise | Stock Option (Right to Buy) | 7,500 | $0.00 | - | |
| Lonnel Coats | Option exercise | Stock Option (Right to Buy) | 1,312 | $0.00 | - | |
| Jeffrey W. Albers | Option exercise | Common Stock | 5,000 | $36.05 | $180K | |
| Jeffrey W. Albers | Open-market sale | Common Stock | 5,000 | $102.00 | $510K | |
| Jeffrey W. Albers | Option exercise | Stock Option (Right to Buy) | 5,000 | $0.00 | - | |
| Fouad Namouni - Officer | Open-market sale | Common Stock | 3,633 | $89.32 | $324K |
BPMC insider trading FAQ
What is the latest insider trade for BPMC?
Blueprint Medicines Corp (BPMC) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-07-17. The full record for BPMC runs to 28 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying BPMC stock?
No insider purchases of BPMC were filed in the last 90 days.
How many insiders are selling BPMC stock?
No insider sales of BPMC were filed in the last 90 days. 20 sales are on record for this company.
Where can I see BPMC SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects BPMC Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Habib J. Dable view on EDGAR
- - Michael Landsittel view on EDGAR
- - Ariel Hurley view on EDGAR
- - John Tsai view on EDGAR
- - L. Becker Hewes view on EDGAR
- - Lonnel Coats view on EDGAR
- - Kate Haviland view on EDGAR
- - Percy H. Carter view on EDGAR
- - Christina Rossi view on EDGAR
- - Fouad Namouni view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where BPMC's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow BPMC with a 7-day demo
- BPMC on your watchlist
- Every BPMC Form 4 filing on record
- Up to 3 months of BPMC price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
